Cancer Gene Therapy Market is segmented by Indication (Large B-Cell Lymphoma, Multiple Myeloma, Acute Lymphoblastic Leukemia, Melanoma, Others), Vector Type (Lentivirus, Retrovirus & Gamma Retrovirus, Adeno-Associated Virus, Modified Herpes Simplex Virus, Adenovirus, Others), Route of Administration (Intravenous, Others), and Region, with forecasts covering the period from 2026 to 2036.
Request for Brochure
The most complete guide to Cancer Gene Therapy Market in 2026